Now available on private prescription!
A “gamechanging” drug that prevents hot flushes and could benefit hundreds of thousands of women has been approved for use in the UK.
The Guardian
VEOZA is a prescription treatment for hot flashes and night sweats. It was proven to reduce the number and severity of day and night hot flashes.* And, for some women, it can start working in as early as one week.†
*Based on clinical studies measuring efficacy at 4 and 12 weeks.
Taken as one tablet once a day – and now available in the UK on private prescription. Contact us to arrange an appointment.
As with all prescription medicines Veozah can cause side effects and may not be suitable for everyone.
For more information, talk to us or your doctor and see Patient Product Information for VEOZA (fezolinetant).
Science has revealed that VMS—also known as Vasomotor Symptoms, the medical name for hot flashes and night sweats due to menopause—isn’t caused by declining estrogen alone.
In fact, we know that a brain chemical called Neurokinin B, or NKB for short, is a trigger of VMS. NKB is found in the temperature control center of your brain, the hypothalamus.
When NKB binds to the receptor in the hypothalamus during menopause it triggers hot flashes and night sweats.
VEOZA is the first prescription treatment of its kind for moderate to severe Vasomotor Symptoms (VMS) due to menopause.
VEOZA is designed to directly block NKB from binding to the receptor. This reduces hot flashes and night sweats due to menopause.
VEOZA is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause. VEOZA is not a hormone. Vasomotor symptoms are the feelings of warmth in the face, neck, and chest, or sudden intense feelings of heat and sweating (“hot flashes” or “hot flushes”).
